Hysolv Animal Health has announced the launch of Salmovac 440, a new live salmonella vaccine for poultry which the company claims gives earlier, stronger and longer-lasting immunity than other salmonella vaccines.
The vaccine is given orally through the water supply in a three-dose regime that protects against Salmonella Enteritidis (SE) and Salmonella Typhimurium (ST). It also protects against other SE strains and the newly-emerging monophasic Salmonella Typhimurium strains.
Hysolv says the advantage for farmers is that the vaccine strain is robust and can survive in more hostile conditions. It therefore remains effective where the water delivery system is less than ideal.
The first dose is administered from Day 1 followed by a second dose at six weeks and a third as early as 11 weeks. Salmovac 440 protects chicks after six days and remains effective for up to 63 weeks after the third vaccination, providing an extra four weeks of protection.
Hysolv says another important benefit to egg producers is that the earlier final vaccination at 11 weeks means that the birds can be moved into the laying house as early as 16 weeks old if required — a significant management advantage on some farms.
During the development of the vaccine it was found that the third live vaccination tended to ‘shut down’ any prolonged shedding of the vaccine strain. This, coupled with the earlier vaccination at 11 weeks, helps solve the issue of the vaccine strain being found at transfer to the layer house. Dr Daniel Windhorst, salmonella vaccine specialist with IDT Biologika, said: "If any should be found, the new PCR (Polymerase Chain Reaction) test shrinks the testing time to just two to three hours."
Daniel added: "Although the UK has one of the lowest percentages of salmonella in its flocks, almost one-third of cases were of S Typhimurium. In most continental countries the percentage is much higher, so the extra cover provided by this vaccine is important."
Salmovac 440 has been approved for use by the British Egg Industry Council, which administers the Lion Code.
Ms Hickman was charged with leaving three dogs, two of which had undergone surgery the day before and one of which was in for monitoring, unattended for more than three hours on 8th November 2022, after falling asleep.
She was then charged with falsifying clinical records to suggest she had made the relevant clinical checks and offered them water when in fact, she'd been asleep.
The final charge was that her actions in falsifying the records were dishonest and misleading.
At the start of the hearing, Ms Hickman admitted all of the charges.
As the charges had been admitted, the Committee considered whether they amounted to serious professional misconduct.
In doing so it noted sections of the Code of Professional Conduct for Veterinary Nurses that relate to making animal health and welfare a veterinary nurse’s primary concern, the need to provide veterinary nursing care that is appropriate and adequate, and the need to keep clear, accurate and detailed clinical and client records.
Dr Kathryn Peaty MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee was in no doubt that the respondent’s failure to monitor properly three patients in an overnight ward in a hospital and the subsequent creation of false records to suggest that appropriate monitoring had taken place amounts to disgraceful conduct in a professional respect.”
Having found serious professional misconduct, the Committee then went on to consider the most appropriate sanction, taking into account both aggravating and mitigating factors.
The Committee found that an adverse health condition had influenced the conduct that had led to the disciplinary hearing – including that she had unintentionally fallen asleep while she should have been monitoring the animals – and so considered this a mitigating factor.
Also, by way of mitigation, the Committee considered that Miss Hickman had fully appreciated the implications of her conduct and expressed remorse at the impact it could have on the public’s trust for the veterinary nursing profession.
It also took into account positive testimonials from current and previous employers, her hitherto unblemished career, and the fact that there was no longer any risk of repetition.
However, in terms of aggravating factors, the Committee took into account that it was a case involving dishonesty, and dishonesty which had not been admitted to the RCVS at an early stage.
In addition, it noted that the conduct involved a risk of injury to animals and a breach of trust towards the owners of those animals.
Dr Peaty added: “The Committee was satisfied that a significant period of suspension would properly reflect the gravity of the respondent’s disgraceful conduct, serve to maintain the reputation of the profession and promote and maintain proper standards of conduct.
"The Committee considered that a period of suspension of six months was sufficient to satisfy this public interest.”
Miss Hickman has 28 days from the sanction being announced to appeal the Committee’s decision.
www.rcvs.org.uk/disciplinary
For the study1, the authors Lucy Norris, Gina Pinchbeck, Peter-John Noble and Alan Radford, analysed data from electronic health records submitted by veterinary practices participating in the Small Animal Veterinary Surveillance Network (SAVSNET).
They found that a total of 132 dogs with cropped ears were seen by vets across a sample size of 500 practices between 2015 and 2022, with numbers peaking in 2021.
The breeds most likely to have cropped ears were the American bulldog, Dobermann, Italian mastiff and bulldog.
In more than 60% of the cases, the dogs had been imported from countries where ear cropping is illegal, such as Romania, Hungary, Bulgaria, Serbia, Spain, Poland and Ireland.
The authors acknowledge that the findings of their research are likely just a small snapshot of the true scale of the ear cropping problem: figures from the 2022 PDSA PAW Report suggest that the true numbers of dogs imported with cropped ears could be as high as 26,000.
RSPCA Head of Companion Animals Samantha Gaines said: "The study provides strong evidence to refute arguments for ear cropping to prevent ear infections, as the breed types identified in Norris and colleagues’ study are not generally predisposed to such infections.
"Rather, this finding adds weight to anecdotal evidence suggesting that the motivation for ear cropping in many dogs is driven by appearance rather than any perceived health benefits.
“It is also possible that some dogs were cropped illegally in the UK using legal importation as a smokescreen for this activity.
"Indeed, it is the RSPCA's experience that many dogs stated as being cropped outside of the UK have histories that would make this highly unlikely.”
Vet Record editor-in-chief Suzanne Jarvis said: “One solution to the importation problem is proposed in the Kept Animals Bill, which is currently stalled in parliament.
"Although there could be potential for fraud around grandfather rights initially, a ban on such importations would ultimately mean that the sight of a dog with cropped ears becomes a thing of the past in the UK.”
https://www.bva.co.uk/take-action/ear-cropping-campaign
Reference
1,219 farmers took part in the survey: 44% beef and 56% dairy. For the first time, the survey was also tailored for the regions. 488 responses came from famers in England, 380 from Scotland, 164 from Wales and 237 from Northern Ireland.
Boehringer Ingelheim’s Matt Yarnall, who led the project, said: "Headline findings are that farmers have regrets about holding onto persistently infected animals (PIs) which, at the end of the day, no-one should be doing.
"The financial benefit of being free of BVD was estimated as being over £90 per cow per year and when asked what impact BVD has had on their herd, the majority of producers highlighted poor fertility and high levels of disease in the herd.”
Boehringer says the identification of persistently infected animals (PIs) through tag and testing, supported by improved herd biosecurity and vaccination, could cost as little as £10 per cow per year, representing a significant return on investment for a disease with severe financial impact.
Matt said: "Herd biosecurity is also hugely variable. The most commonly selected response was operating a closed herd but, as most practitioners will know, the definition of a true closed herd and the real-life execution of that can be two very different things."
Highlighting one of the other major challenges for producers in cattle-dense areas, results from Scotland that showed that 51% of farmers with neighbouring cattle are worried about their neighbours' BVD status.
Matt said: "Perhaps the most alarming finding was the lack of awareness of the intricacies of some BVD vaccination courses, especially around when they need to be restarted, in order to achieve the protection needed."
2017 survey data from last year showed that 71% of producers were failing to achieve adequate protection when using a BVD vaccine that requires a booster six months after the primary course.
Boehringer says the results showed this is mostly down to not properly understanding the exact nature of the timings for the two-dose primary course, dates of service and calving and then the booster date.
Matt added: "For any practitioner advising clients, the 2018 finding that a shocking 85% haven’t restarted a vaccination course when the majority should have done, should ideally serve as a clear call to action."
For more information about the findings of the National BVD Survey, email bvdzero.uk@boehringer-ingelheim.com.
Enrobactin contains enrofloxacin but is uniquely available in 10ml bottles for convenient dispensing in practice.
Enrobactin can be used to treat digestive, respiratory tract and skin and wound infections and features a distinctive caramel aroma.
Madeline Haynes, Product Manager, said: "Offering practices solutions which are efficacious but also easy to use is a key focus at Virbac, particularly given the importance in practice of using antibiotics responsibly and accurately across all species. Enrobactin is a good example of this and we are pleased to launch it."
The removal of names from the RCVS Register of Veterinary Surgeons for non-payment of retention fees is now complete, with 386 veterinary surgeons having been removed, compared with 616 last year.
The RCVS says that the administration involved with removing a name for non-payment is time-consuming and costly. Hence, to be restored to the Register, the veterinary surgeon must pay the appropriate annual retention fee, and the restoration fee, currently £294, which multiplies each time if fees are not paid in successive years.
The College writes to members' Register addresses to remind them when fees are due and, where an email address is maintained by the member as part of their formal record, also sends an email. It is, however, the responsibility of members to inform the RCVS Registration Department of any changes to their contact details and to ensure that payment is made. It is illegal for veterinary surgeons to practise or undertake any veterinary-related activities if their name does not appear on the RCVS Register as a home-practising member.
To help ensure that members removed for non-payment are aware that they have been removed from the Register, the full list of those removed for non-payment and not restored by 10 June can be downloaded from RCVSonline. The current status of individual veterinary surgeons can be checked online (www.rcvs.org.uk/checkregister).
A veterinary surgeon whose name has been removed from the Register and who wishes to restore him or herself should view the information on restoration to the Register.
Alternatively, please ring the RCVS Registration Department on 020 7202 0707. Restorations made since 10 June are not shown on this list.
In 2020, BSAVA Congress will have been held at the ICC Birmingham for thirty years. However, recent years have seen ever greater competition from the London Vet Show, so the plan to revitalise the event further north at an award-winning new venue with such good transport links seems to make a lot of sense.
Manchester Central's size also means that unlike in Birmingham, the commercial exhibition, lectures and demonstrations will all take place under one roof, maximising the use of delegates' time.
Angharad Belcher, Head of BSAVA Congress said: "We’ve had a first-class experience in Birmingham, and we could not have asked for more from the venue. We know that 2019 and 2020 will continue to be popular, however, it’s time to move BSAVA Congress forward and revitalise the offering to our delegates and exhibitors by bringing everything into one building. The move to Manchester enables us to invest even more in speakers and delegate experiences, to make BSAVA’s education programme truly unsurpassable."
BSAVA President Philip Lhermette said: "It’s very much a new city for a new Congress and celebrations will be in order. Manchester lends itself perfectly to a timely transformation for Congress. We will be completely re-branding the event, modernising the CPD programme and making the best possible use of every minute of every delegate’s time over the full four days. We have been working closely with the city and venue in practical terms to offer a whole suite of options to delegates and exhibitors, from irresistible new socials and extensive accommodation choices, to easy transport routes."
Shaun Hinds, CEO of Manchester Central said: "After getting to know the association and their vision, it was clear that they wanted to transform the experience of their delegates. The ambition of the association matches that of the city and Manchester has the perfect blend of venue and vibrancy to develop the BSAVA Congress of the future. We’re delighted to be welcoming them in 2021 and we’ll work hard with the organisers to create a unique and remarkable experience for their delegates, exhibitors, partners and all visitors."
In the study titled “Safety of early postoperative hydrotherapy in dogs undergoing thoracolumbar hemilaminectomy”, the medical records of a single referral hospital in Sweden were retrospectively reviewed to identify dogs that had been treated with hemilaminectomy for acute or chronic thoracolumbar IVDE and had commenced hydrotherapy within five days after surgery.
Information collected from the medical records included signalment, presenting clinical signs, severity of neurological signs, initiation and duration of hydrotherapy, postoperative complications and follow-up.
Postoperative complications were considered major if there was a need for hospitalisation, surgery or if the dog died or was euthanised as a direct consequence of the complication.
A complication was deemed minor if outpatient medical treatment was sufficient to rectify it.
A total of 83 dogs were included in the study.
Hydrotherapy was started within a mean of 2.7 (one to five) days after surgery and consisted of swimming without underwater treadmill (UWTM) in dogs with severe paraparesis or paraplegia.
With neurological improvement, and when supported ambulation was possible, UWTM was initiated.
Ninety-six percent of the dogs used swimming as postoperative hydrotherapy, starting with a mean of 2.7 days after surgery, fifty-seven percent of the dogs used UWTM as the postoperative hydrotherapy, starting with a mean of 13 days after surgery.
Forty-five percent of dogs used both hydrotherapeutic modalities.
Dr Abtin Morjarradi, corresponding author for the paper, said: “A total of 10 minor complications were recorded during the study period, including surgical site infection (SSI) (n=5), diarrhoea (n=4) and urinary tract infection (n=1).
Major complications were recorded in 26 dogs during the study period and included euthanasia (n=13), acute dermatitis (n=1), spinal abscess (n=1) and disc extrusion (n=1).
Reasons for euthanasia were urinary incontinence (n=5), lack of neurological improvement (n=2), clinical suspicion of progressive myelomalacia (PMM) (n=2), persistent pain (n=1), aggression (n=1) and widespread cellulitis with an abscess caudal to the right stifle without known cause (n=1).”
Abtin added: “Follow-up visits for 71 dogs were performed at a mean of 15.3 (9 to 30) days, and 68 dogs at a mean of 45.9 (30 to 111) days, after surgery.
"At the first follow-up visit 68% of the dogs were ambulatory with Modified Frankel Score (MFS) 4 or higher.
"At the last follow-up visit 97% of the dogs were ambulatory with MFS 4 or higher, with 34% demonstrating normal neurological function. None of these dogs deteriorated after the initiation time of hydrotherapy.”
Nicola Di Girolamo, Editor of JSAP, said: “Whilst previous studies indicate that early rehabilitation may be beneficial after acute spinal cord injury, the optimal timing to start hydrotherapy is unclear.
“Despite a high number of complications being recorded in the present study, it is not clear how many of these complications were directly related to the initiation time of hydrotherapy and therefore further research is required.”
The full article can be found in the December issue of the Journal of Small Animal Practice: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13412.
PawSquad, which was founded in 2015 by Diwaker Singh and Radu Georgescu, offers veterinary consultations by video and live text chat in the United Kingdom. IVC says it continue to operate as an autonomous entity within the IVC group.
PawSquad CEO, Dr Mark Boddy MRCVS (pictured right) said: “Our network of experienced veterinarians has already helped many thousands of pets in the UK, providing medical advice, emergency triage and preventive health plans. Being part of IVC will allow us to help even more pets and to continue to work positively and collaboratively with the veterinary profession, as well as expand geographically.”
Stuart Caton, Chief Commercial Officer at IVC Evidensia said: "Telemedicine will support the efforts of the group to make high quality veterinary care more accessible to pet owners, lowering the barriers to engagement with the veterinary profession. It’s an excellent acquisition that will further complement the group as pet services grow and evolve in the future. We are delighted the entire PawSquad team will continue with the business supporting their corporate and private clients as before.”
IVC says the accessibility of the PawSquad service encourages pet owners to seek professional advice earlier and more frequently, with around half of all queries being referred for necessary in-clinic follow-up and otherwise providing much valued reassurance and peace of mind.
The company also says telemedicine is particularly appreciated by cat owners or those with nervous dogs, where the stress of a clinic visit can sometimes result in those pets missing out on veterinary care.
PawSquad Chairman and Founder, Diwaker Singh said: “We are pet lovers and launched PawSquad with the objective of making sure that pet owners have instant 24/7 access to quality pet care, accessible from their homes. Towards this end, PawSquad is a great success. The service has grown significantly, confirming there is a clear need for this service. IVC Evidensia’s extensive network will help the business strengthen and grow to even greater heights.”
The awards celebrate the achievements of remarkable people from the farming, veterinary and charity industries, who go beyond the call of duty to better the lives of animals around the world. Nominations were submitted by friends, family, clients and colleagues.
Spanning six categories, the shortlist for the 2018 Ceva Animal Welfare Awards is as follows:
Chris Laurence Vet of the Year Award supported by Your Dog and Your Cat magazines
Vet Nurse of the Year Award supported by Agria Pet Insurance
Charity Team of the Year supported by PDSA
Charitable Contribution of the Year supported by Blue Cross
Farm Animal Welfare Award supported by R.A.B.I. and NADIS
International Cat Care Welfare Award
International Cat Care will be choosing the winner of this award from its extensive membership base. The winner will be announced at the awards’ ceremony.
In addition to the scheduled categories, the judges have granted one additional award in special recognition of an individual’s lifetime commitment to animal welfare.
The shortlist for each award was decided following a day of deliberations by a panel of judges chaired by retired veterinary surgeon, Chris Laurence MBE FRCVS. Chris is chairman of the Animal Welfare Foundation, the Canine and Feline Sector Group of the Animal Health and Welfare Board and BVBA (British Veterinary Behaviour Association) and before retiring he was chief veterinary officer at the RSPCA and veterinary director of Dogs Trust. He is also involved in a number of charities and is a trustee of the Pet Blood Bank and the Bella Moss Foundation.
Chris said: "Judging the ever-increasing number of nominations takes a lot of work, just to read them all let alone deciding who should go forward as a finalist. The standard of nomination improves every year and each is an inspiration to the judges because of the selfless effort put in by each nominee to improve animal welfare, often in the most difficult circumstances."
Cuneyt Seckin, managing director of Ceva Animal Health, added: "Year-on-year we are amazed and humbled by the individuals and organisations who dedicate their lives to enhance and improve animal welfare both in the UK and abroad. We are delighted to be able to honour these people, while highlighting their important work to a wider audience."
The winners will be announced and presented with their awards during a ceremony held in Birmingham ahead of BSAVA Congress on 4th April 2018.
To find out more about the awards, visit: www.cevawelfareawards.com.
Neptra has been approved for the treatment of acute canine otitis externa or acute exacerbations of recurrent otitis caused by mixed infections of susceptible strains of bacteria sensitive to florfenicol (Staphylococcus pseudintermedius) and fungi sensitive to terbinafine (Malassezia pachydermatis), by the European Commission.
Mario Andreoli, Head of Marketing at Bayer Animal Health, said: "Otitis externa is a common disease in dogs and a leading cause why owners take their dog to a veterinarian.
"Neptra offers a key advantage, unlike competing products, it requires just one dose, administered by the veterinarian in the practice."
No at-home applications by the dog owner are required. The treatment stays in the hands of the vet who has full control over compliance.
Mario added: "With Neptra we provide a high-quality veterinary treatment that is convenient for the dog owner and ensures the well-being of dogs with a proper, effective application."
VetSurgeon understands the new product will be available in the UK in January 2020.
‘Is neutering dogs doing more harm than good?’ (BVA Congress Theatre, Thursday 16th November 2023 at 10.30am), will explore the latest research into the science of neutering and its impact on dog health and welfare, particularly on behaviour, and will also consider the role of non-surgical alternatives.
The session will be chaired by BVA President Dr Anna Judson, joined by:
The BVA says statistics from its Voice of the Veterinary Profession survey show that among clients who chose to neuter their dogs last year, only 6% picked non-surgical options.
Awareness of these options is low, with vets reporting that 9% of their clients had requested information about non-surgical options when considering neutering, such as sustained-release implants to suppress testosterone production in male dogs.
Among those who considered non-surgical options, clients cited the cost and need for repeat treatments as their main concerns (mentioned by 67% and 58% of vets, respectively), followed by individual variation in the effect and duration of non-surgical alternatives (22% of vets).
Anna said: “Canine neutering is a firmly established part of preventive pet healthcare in the UK, but it is also very much a live discussion within the veterinary profession, with a healthy ongoing debate around its merits and risks, based on evolving evidence.
"BVA’s survey shows low awareness among clients about all available neutering options for their pets, with only a tiny percentage choosing to go down the non-surgical route.
“Our BVA Congress discussion will offer vet professionals in small animal practice insight into the latest research on neutering, including potential longer-term impacts on a dog’s health and behaviour, and views on what that might mean for how vets discuss neutering options with clients.
"The panellists will also share useful tips on how to deal with clients’ questions about surgical and non-surgical options for their pets.”
https://bvajournals.onlinelibrary.wiley.com/toc/20427670/2023/193/S1
The British Veterinary Association has responded to 'alarmist' headlines linking contact with cats to schizophrenia due to the risks posed by the parasite Toxoplasma gondii.
The report in today's Independent contains some important messages regarding the need for good personal hygiene and the need for pregnant women and immuno-compromised groups to be aware of the risks. However, the BVA says it is concerned that the headlines could cause significant alarm to cat owners.
Most people who become infected are asymptomatic but 10-20% can show transient symptoms which are flu-like. There is a more serious risk to pregnant women and those who are immuno-compromised, but as with all infections common sense and good personal hygiene reduces the risk significantly and the BVA says there is no reason that families with, or those intending to have, children shouldn't have pet cats.
As outlined in the article sources of infection include eating undercooked meat and vegetables that have not been washed properly and contact with cats. It is not known which the greater source of infection is but according to the BVA, anecdotal evidence suggests that meat is likely to be more important than contact with cats. The BVA says it echoes advice that meat should be prepared and cooked properly, and offers the following hygiene advice for cat owners:
BVA Past President and veterinary surgeon Harvey Locke said: "While the facts are true, the headlines in this story have been quite alarmist and we are very keen to reassure cat owners that the risks can be managed with good basic hygiene and common sense.
"The biggest threat is to pregnant women and those who are immuno-compromised, which we have known for some time. It is useful to reiterate that they should take extra care but there is no need for people to get rid of their pet cats or choose not to have cats as pets."
Sarah, who practices at Southfields Veterinary Specialists, was already a European and Royal College Specialist in oncology. Now, after studying for a year and passing the European College of Veterinary Internal Medicine (ECVIM) exams this autumn, she has now been recognised as a European Specialist in radiation oncology as well.
Sarah said: "I intend to use my experience to grow the radiation and oncology service at Southfields and, with the benefit of our new linear accelerator and state-of-the-art hospital, deliver the most advanced treatment options for our veterinary patients.
"I also intend to use my experience and expertise to contribute to the further development of radiation oncology as a specialist qualification in Europe."
Congratulations Sarah!
Bovilis Rotavec Corona is used for the active immunisation of pregnant cows and heifers, 12-3 weeks pre-calving, to raise antibodies against rotavirus, coronavirus and E. coli F5 (K99). Calves gain protection by drinking the fortified colostrum from their vaccinated mothers.
The company says the new license indication will mean greater usage flexibility for UK cattle producers focusing on immunity-led prevention of infectious calf scours.
MSD ruminant veterinary adviser Dr Kat Baxter-Smith said: "On the old license, this vaccine needed to be used within eight hours of opening, so this will be a significant benefit-led change for suckler beef and dairy producers.
"For all-year-round calving dairy herds, for example – that may want to vaccinate successive pregnant dams on different days – it will make an opened bottle of vaccine last much longer. Those running batch calving herds with a long calving period should also benefit. We hope this will help reduce unnecessary wastage of the vaccine on farm and save farmers money.”
MSD says it will still be crucial to store the vaccine properly – upright and refrigerated (at 2-8°C) before and after broaching, and after first use. A broached vial will be able to be used once more during the next 28 days after the first vaccination event and then discarded. Vaccination equipment such as needles and syringes should be sterilized. Use of a multi-dose syringe to minimise vaccine contamination and excessive broaching is recommended.
The vaccine vials should still be shaken well before use. The injection should be made through an area of clean, dry skin with precautions taken against contamination.
NDSR’s European Specialist in neurology and neurosurgery Niklas Bergknut is performing the surgery.
He said: "This type of surgery for dogs is not performed in many clinics across the country.
"The pituitary gland is, of course, a very small gland which is very close to the brain, so it requires considerable expertise to perform the operation, followed by a lot of after-care to help the animal recover properly after surgery.
"The pituitary gland produces hormones which are essential for life, so it is then vital to constantly monitor the dog, its blood, hormones and fluid levels both during surgery and for a longer period after surgery.
"Although surgery may be challenging, the aftercare can be even more challenging and requires very skilled internal medicine specialists to manage the patients after surgery.
"Our medics and nurses carry out various blood tests and manage the fluid balance every hour after surgery and all the way through to the dog going home.
"Every department in the hospital has to work closely together to ensure the best possible treatment and the best possible outcome."
Niklas, who learned the technique from Bjorn Meij, Professor of Surgery at the University of Utrecht, described how the operation is performed. He said: "We go in through the mouth, up through the soft palate and into the underside of the cranium. Then you drill a little hole to access the tumour that way.
"It is obviously essential to make sure you are in exactly the right place or the outcome could be disastrous.
"It is also important to operate as early as possible before the tumour gets too big.
"Trying to remove a big tumour is more difficult and holds greater risks because of the damage that can be done to the surrounding brain in attempting to remove the tumour."
Niklas says that if surgery is successful, the results are impressive, with most dogs making a full recovery and not suffering any recurrence of the tumours, a better outcome than treating the dogs with traditional methods such as radiotherapy.
He added: "Removing the tumour like this is the only way of permanently treating tumours of this type. Radiotherapy is very good too but there is a much larger likelihood of the tumour growing back."
For more information, visit www.ndsr.co.uk.
BVA’s Voice of the Veterinary Profession survey panel, which polls over 1,000 UK vets, highlighted that many vets support the higher welfare standards of British farming, with 9 out of 10 vets saying they would be more likely to buy food if it was labelled as British or locally sourced. Over three quarters of vets said that they would be more likely to buy free-range (77%) or food that carried a Farm Assurance Scheme label (over 50% for Red Tractor and RSPCA Assured; formerly known as Freedom Food).
BVA President Sean Wensley encouraged consumers to check labels as the warmer weather sees BBQs and picnics take centre stage in gatherings of families and friends. He said: "Animal welfare should be a paramount consideration whether we’re thinking about purchasing pets or the food we eat. For vets it’s a top priority that the animals we rear for food have a good life and a humane death.
"Vets are not alone in caring about where their food comes from. To support high standards of animal welfare, all of us can vote for good animal health and welfare through our thoughtful meat, fish, and dairy purchases and send a strong message to food producers and retailers this summer."
BVA’s Voice of the Veterinary Profession survey panel also revealed that 9 out of 10 vets would be less likely to buy meat or fish if it was labelled as not stunned prior to slaughter.
BVA is leading a campaign to end slaughter without pre-stunning for animal welfare reasons and calling for better labelling of food to help consumers make pro-animal welfare choices.
To find out more about BVA’s campaign to end non-stun slaughter, visit: http://www.bva.co.uk/News-campaigns-and-policy/Campaigns/An-end-to-non-stun-slaughter
Image: CC BY-SA 2.0 cyclonebill
Merial Animal Health has launched Certifect, a new POM flea and tick treatment for dogs.
The product was launched at a series of presentations by the survival and bushcraft expert, Ray Mears (pictured right) last week.
The connection between Ray Mears and a new flea and tick treatment for domestic dogs became clear as he recounted his experience of contracting Lyme Disease in the UK. Indeed, by the time he'd finished describing the crippling pain he'd suffered and the industrial quantities of morphine and tramadol he'd needed, most vets in the room were probably ready to place an order for a tonne of the new product.
But to dismiss it as just a polished marketing exercise would be wrong. According to the Health Protection Agency, cases of Lyme disease in people have risen from 296 in 2001 to 953 in 2010. It is thought that because the disease is difficult to diagnose, it is likely to be significantly under-reported. In addition, a study by Faith Smith from the University of Bristol last year found that of 3534 dogs examined, 810 (22.9%) were carrying at least one tick.
So, what about the new product? Well, it's essentially Frontline Combo (fipronil + the insect growth regulator, S-methoprine) but with added amitraz. At the low dose contained in Certifect, Merial explained that amitraz doesn't demonstrate acaricidal properties itself, but instead potentiates the effect of the fipronil and causes ticks to detach or fail to attach. It also causes ticks to move around more than they do normally, thereby exposing them to more fipronil.
Merial says the acaricidal effect of Certifect can be seen two hours after application, and that more than 90% of ticks are eliminated within 24 hours. After treatment, Certifect prevented 94.5% to 100% of ticks attaching until day 29, thereby reducing the risk of disease transmission. In terms of integrated flea control, think Frontline Combo.
Certifect can be used on pregnant and lactating bitches, on puppies from 8 weeks weighing more than 2kg, and on dogs which live in households with cats.
Novartis Animal Health has issued the following statement concerning the supply of acepromazine (ACP) injectable in the UK:
"Recent upgrades to Novartis Animal Health’s manufacturing plant in the UK have resulted in the site becoming a worldwide centre of excellence for the production of bulk liquids. This upgrade has had an impact on the manufacture of ACP 2mg/ml and 10mg/ml injectable products, which will no longer be produced in the UK.
From January 2011, Novartis Animal Health will no longer be able to supply ACP Injection 2mg/ml or ACP Injection 10mg/ml to wholesalers. However, it is not Novartis’ intention to discontinue the supply of acepromazine injectable; in order to ensure consistency of supply to the UK market the company will be importing the Vetoquinol French product Calmivet.
Calmivet is a monovalent acepromazine injection licensed for use in dogs, cats and horses, available as a 5mg/ml injection, 50ml vial.
In order to obtain Calmivet from wholesalers, veterinarians will need to apply for a free of charge Special Import Certificate from the VMD. This can be completed on line at www.vmd.gov.uk.
It is anticipated that this situation will continue for at least the first 6 months of 2011, until an alternative manufacturing site is established. As soon as we have more information on the timelines this will be communicated.
A full communication including a prep room reminder poster and Calmivet product leaflet has been mailed to all UK practices.
Vetoquinol UK are not responsible for the distribution or technical support of this product, so any queries should be directed to Novartis Animal Health UK on 01276 694402.
The production and supply of ACP Tablets 10mg remains unaffected."
The authors say that the prognosis for dogs with stage II Kiupel high-grade cutaneous mast cell tumours has historically been considered poor.
However, the removal of metastatic regional lymph nodes in more recent research has been associated with a better outcome in canine cutaneous mast cell tumours.
For this study1, dogs with a histological diagnosis of overt lymph node metastasis that underwent lymphadenectomy (n = 31) were compared with those with a cytological diagnosis of regional lymph node metastasis, that did not undergo excision (n 18).
The study was a multi-institutional retrospective cohort study, using electronic medical records from four European institutions to identify dogs for inclusion.
The study found that dogs with Kiupel high-grade cutaneous mast cell tumours undergoing lymphadenectomy of HN3 lymph nodes as part of their primary surgery in addition to adjuvant medical treatment had a significant improvement in time to progression and survival time compared with those dogs not undergoing the procedure.
Lack of lymphadenectomy was the only variable significantly associated with a higher risk of nodal progression.
Dogs underwent lymphadenectomy of one peripheral lymph node in most cases.
The authors says that a higher number of lymph nodes or the removal of intracavitary lymph nodes might be associated with an increased incidence of postoperative morbidity.
They add that the findings warrant further exploration of the effect of surgical extirpation of metastatic sentinel lymph nodes and the number of lymph nodes removed on outcome in dogs with Kiupel high-grade cutaneous mast cell tumours.
Nicola Di Girolamo, Editor of JSAP said: “It is really encouraging to see collaborations from multiple institutions like the study presented here.
"Including multiple institutions in a retrospective cohort study, does not only ensure a higher sample size, but also ensure a higher generalisability of the results.
"Meaning that it is more likely that the differences observed in this study are also going to be observed at different practices and with different clinicians.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13525
The Kennel Club has announced the results of a survey of 329 Breed Kennel Rescue organisations which has revealed that over 50% of dogs given up for rehoming are given up by women, compared to 17% by men and 27% by couples who made the decision jointly.
The Kennel Club said the survey also revealed lifestyle changes, a lack of training and time to look after the family pet adequately are the main reasons why dogs are rehomed.
Caroline Kisko, Kennel Club Secretary, said: "People really need to explore their reasons for wanting a dog in the first place, do the research properly and invest time into training their dog. We are seeing an increasing number of owners being driven by celebrity trends in choice of dog breed, such as the French Bulldog, owned by Millie Mackintosh, Jessie J and Jonathan Ross.
"Every year dogs are abandoned or given up when the novelty wears off. Dogs are a lifelong commitment and anyone considering getting a pet needs to be sure that they will be able to properly care for the animal for the rest of its life."
Kennel Club Breed Rescue organisations last year rehomed over 20,000 dogs, more than Dogs Trust and Battersea Dogs & Cats Home combined. January was revealed to be the busiest month, highlighting the impact of many families being unprepared for getting a dog and potentially still buying them as a Christmas gift, despite advice to the contrary. More than one in three breed rescue organisations reported an increase of dogs needing to be rehomed compared with 2012.
Caroline continued: "Although not as well-known as other organisations, Kennel Club Breed Rescues work incredibly hard to support their breed. They are set up and run by people passionate about dogs and their particular breed in particular. There is a breed rescue organisation for almost every one of the 212 breeds of pedigree dog in the UK, and more than one in three of the breed rescue organisations also accept crossbreeds as well as pedigrees.
"Breed rescue is a fantastic place to consider when looking for a dog. The expert staff and volunteers will often know the full history of the dogs in their care and provide you with invaluable knowledge on the breed and tips for caring for individual dogs to make sure the dogs find a family for life."
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, has opened a new discussion about whether VAT on vet fees for pets should be dropped.
The discussion has been opened by this month's Vet Futures guest blogger, Stuart Winter, the Sunday Express small animal columnist and a campaigner to end VAT on pet fees.
Stuart argues that owning a pet is not a luxury to be taxed when they need medical intervention, because owning a companion improves the health and wellbeing of its owner.
He writes that removing VAT on veterinary fees for domestic animals, or at least reducing it to five pence in the pound, would improve the nation's animal welfare. It would allow low-income families to seek medical attention earlier, he argues, while allowing more owners to afford and take out pet insurance.
He says that shifting Government thinking on the subject might be a Herculean task, but that doesn't mean we shouldn't campaign for its removal. "No Chancellor delights in losing revenue. Treating, curing and caring for sick and injured animals is nothing more than a service and services are ripe to be harvested.
"It is time for a counter argument. Pet ownership is not a luxury. It is more than a privilege. Is it not a human right? Welcoming animals into our lives makes our lives more fulfilled and more civilised."
To tie in with the discussion, Vet Futures is inviting vets to take part in a poll which asks: "Would you agree that VAT should no longer be levelled on vet fees?"
The College is encouraging members of the veterinary team and the public to take part in the poll so that it can generate debate on the issue of VAT and better understand the full consequences if it was removed.
January's poll asked members of the profession if they could recognise the signs of mental ill-health in a colleague. Reassuringly, just over half (58%) of the 65 respondents said they would be able to recognise the signs, although that leaves 40% who would not feel comfortable in their ability to do so.
To read Stuart Winter's blog, contribute to the discussion and vote in the poll, visit www.vetfutures.org.uk
The webinar, which will be streamed live at 8pm on Wednesday 20th November and will be available to watch for six months thereafter, is being presented by James Husband, an RCVS Specialist in cattle health & production.
Topics will include oxidative stress, its impact on cattle performance and the role of trace minerals in immunity and cattle health. The webinar will also cover the current complexities of oral supplementation including absorption and mineral antagonism, along with offering information about the latest innovation to boost trace mineral availability during high demand periods in the production and breeding life cycle.
To register for the webinar, visit: https://www.thewebinarvet.com/pages/register-free-role-trace-minerals-cattle-health-performance-new-veterinary-approach-boost-trace-mineral-availability/
All vets who view the webinar, either live or as a recording on the website, will be able to download a CPD certificate.
Merial Animal Health has announced that it has purchased the the anti-inflammatory treatment for lameness in horses, Hyonate® (sodium hyaluronate), from Bayer.
Merial's equine marketing and technical manager, Louise Radford MRCVS said: "Hyonate is an established treatment of lameness in horses due to non-infectious inflammation of joints, using both intra-articular (IA) and intravenous (IV) injection.
"The beneficial effects of HA supplementation are attributable to the anti-inflammatory effects, improvement in viscoelastic properties of the synovial fluid, and interaction with the synovial membrane affecting pain transmission and joint metabolism¹."
For more information telephone Customer Support on 0870 6000123 or contact your local Merial Equine Specialist.
The clinic is led by Sebastien Behr MRCVS, an RCVS Specialist in Neurology. Patients will benefit from access to the referral centre's MRI scanner and its specialist imaging, anaesthesia and neurology teams.
Dr Behr said: "We are very excited to have launched this specialist clinic. Following detailed consultations with pet owners, the animals will be treated to the very highest level and bespoke care designed for each patient."
The practice is offering a fixed price package for routine diagnostic procedures.
For more information, visit www.willows.uk.net or contact the neurology team on 0121 721 7070.